(Q46093703)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

4 March 2020

main subject

1 reference

11

Jean-Charles Soria

0 references

Lecia V Sequist

5

object named as

Lecia V Sequist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Chris Karlovich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jonathan W Goldman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jong-Mu Sun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Elaina Mann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Krzysztof Konopa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Wei Wen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Philipp Angenendt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Leora Horn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

David Spigel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Benjamin Solomon

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

D Ross Camidge

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Shirish Gadgeel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Cloud Paweletz

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Lin Wu

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sean Chien

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Patrick O'Donnell

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Shannon Matheny

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Darrin Despain

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Lindsey Rolfe

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Mitch Raponi

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Andrew R Allen

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Keunchil Park

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Heather Wakelee

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Jean-Charles Soria

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

8 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

2386-2395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status

4 March 2020

cites work

1 reference

12 December 2020

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

12 December 2020

Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib

1 reference

12 December 2020

Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays.

1 reference

12 December 2020

Detection and quantification of mutations in the plasma of patients with colorectal tumors

1 reference

12 December 2020

Analysis of circulating tumor DNA to monitor metastatic breast cancer

1 reference

12 December 2020

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

1 reference

12 December 2020

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

1 reference

12 December 2020

Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

1 reference

12 December 2020

Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.

1 reference

12 December 2020

Going with the flow: from circulating tumor cells to DNA.

1 reference

12 December 2020

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

1 reference

12 December 2020

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

1 reference

12 December 2020

Liquid biopsies: genotyping circulating tumor DNA

1 reference

12 December 2020

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

12 December 2020

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers

1 reference

12 December 2020

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

12 December 2020

Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients

1 reference

12 December 2020

Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma.

1 reference

12 December 2020

Winnowing DNA for rare sequences: highly specific sequence and methylation based enrichment

1 reference

12 December 2020

Screening for epidermal growth factor receptor mutations in lung cancer

1 reference

12 December 2020

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

1 reference

12 December 2020

Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

1 reference

12 December 2020

Detection of circulating tumor DNA in early- and late-stage human malignancies

1 reference

12 December 2020

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood

1 reference

12 December 2020

The BATTLE trial: personalizing therapy for lung cancer

1 reference

12 December 2020

Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.

1 reference

12 December 2020

Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor

1 reference

12 December 2020

Detection of mutations in EGFR in circulating lung-cancer cells

1 reference

12 December 2020

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular

1 reference

12 December 2020

Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer

1 reference

12 December 2020

Rociletinib in EGFR-mutated non-small-cell lung cancer

1 reference

12 December 2020

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.

1 reference

12 December 2020

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

1 reference

12 December 2020

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.

1 reference

12 December 2020

Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer

1 reference

12 December 2020

Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.

1 reference

12 December 2020

10.1158/1078-0432.CCR-15-1260

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26747242%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference